Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Philipp Schreiner"'
Autor:
Jeanine Wakim El-Khoury, Ekaterina Safroneeva, Catherine Saner, Jean-Benoit Rossel, Sven Trelle, Marcel Zwahlen, Luc Biedermann, Andrea Kreienbuehl, Thomas Greuter, Philipp Schreiner, Peter Netzer, Annett Franke, Stephan Brand, Chantal Hasler, Patrick Aepli, Emanuel Burri, Achim Weber, Christine Sempoux, Ruggero Biral, Wolfram Jochum, Joachim Diebold, Niels Willi, Alex Straumann, Alain M. Schoepfer
Publikováno v:
Inflammatory Intestinal Diseases, Vol 9, Iss 1, Pp 165-173 (2024)
Introduction: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS) is a national cohort that was established in 2015 with the aim of improving quality of care of affected adults with eosinophilic esophagitis (EoE). Between 2020 and 2022, paper que
Externí odkaz:
https://doaj.org/article/9cc813641253435cb4165babb8fda911
Autor:
Severin A. Lautenschlager, Mamadou Pathé Barry, Gerhard Rogler, Luc Biedermann, Philipp Schreiner, Alexander R. Siebenhüner, Swiss IBD Cohort Study Group
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Various environmental risk factors have been associated with the pathogenesis of inflammatory bowel disease. In this study we aimed to identify lifestyle factors that affect the onset of Crohn’s disease and ulcerative colitis. M
Externí odkaz:
https://doaj.org/article/050e64a7b7204c5d8e745f68f1130a31
Autor:
Brian M. Lang, Martina Ledergerber, Sebastian Bruno Ulrich Jordi, Niklas Krupka, Luc Biedermann, Philipp Schreiner, Pascal Juillerat, Jacqueline Wyss, Stephan R. Vavricka, Jonas Zeitz, Roland von Känel, Gerhard Rogler, Niko Beerenwinkel, Benjamin Misselwitz
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: While the detrimental impact of negative emotions on the clinical course of inflammatory bowel disease (IBD) and quality of life has been extensively investigated, evidence for a potential impact of positive emotions is scarce. Objectives
Externí odkaz:
https://doaj.org/article/821caaed25dc40018285a2c701013436
Autor:
Florian F. Hildenbrand, Fritz R. Murray, Roland von Känel, Ansgar R. Deibel, Philipp Schreiner, Jutta Ernst, Carl M. Zipser, Soenke Böettger
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Background and AimsDelirium is the most common acute neuropsychiatric syndrome in hospitalized patients. Higher age and cognitive impairment are known predisposing risk factors in general hospital populations. However, the interrelation with precipit
Externí odkaz:
https://doaj.org/article/8ad1d44cf3d44d8ca3126ede7f0042aa
Autor:
Martina Ledergerber, Brian M. Lang, Henriette Heinrich, Luc Biedermann, Stefan Begré, Jonas Zeitz, Niklas Krupka, Andreas Rickenbacher, Matthias Turina, Thomas Greuter, Philipp Schreiner, René Roth, Alexander Siebenhüner, Stephan R. Vavricka, Gerhard Rogler, Niko Beerenwinkel, Benjamin Misselwitz, the Swiss IBD Cohort Study Group
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Abdominal pain is a frequent symptom in patients with inflammatory bowel disease (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC). Pain can result from ongoing inflammation or functional disorders imitating irrit
Externí odkaz:
https://doaj.org/article/99fb7581359447d1a6f178e77e52a37f
Autor:
Kathrin Perrig, Niklas Krupka, Sebastian Bruno Ulrich Jordi, Jean-Benoît Rossel, Luc Biedermann, Thomas Greuter, Philipp Schreiner, Stephan R. Vavricka, Pascal Juillerat, Emanuel Burri, Dorothee Zimmermann, Michel H. Maillard, Michael Christian Sulz, Stephan Brand, Gerhard Rogler, Benjamin Misselwitz
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Tumor necrosis factor (TNF) inhibitors have improved treatment of ulcerative colitis (UC), but loss of response remains a frequent problem. The anti-TNF agent, golimumab, was approved in Switzerland for the treatment of UC in 2014. This s
Externí odkaz:
https://doaj.org/article/3dc3da4e952b4b73bcb7635cd040ba58
Autor:
Rahel Bianchi, Barry Mamadou-Pathé, Roland von Känel, René Roth, Philipp Schreiner, Jean-Benoit Rossel, Sabine Burk, Babara Dora, Patrizia Kloth, Andreas Rickenbacher, Matthias Turina, Thomas Greuter, Benjamin Misselwitz, Michael Scharl, Gerhard Rogler, Luc Biedermann, or the Swiss IBD cohort study
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0274665 (2022)
BackgroundLittle is known about the impact of ostomy formation in inflammatory bowel disease patients on course of disease, psychological well-being, quality of life and working capacity.MethodsWe analyzed patients over a follow-up of up to 16 years
Externí odkaz:
https://doaj.org/article/7f60beaeb4674a0ca91baa2abcf4cda9
Autor:
Severin A. Lautenschlager, Nicolas Fournier, Luc Biedermann, Valerie Pittet, Philipp Schreiner, Benjamin Misselwitz, Michael Scharl, Gerhard Rogler, Alexander R. Siebenhüner
Publikováno v:
Inflammatory Intestinal Diseases, Pp 1-10 (2020)
Introduction: The pathophysiology of inflammatory bowel disease (IBD) is incompletely understood. Current concepts imply that environmental factors (EFs) trigger disease onset as well as flares in genetically susceptible individuals. Objective: The o
Externí odkaz:
https://doaj.org/article/cb23b8db819e4b1abce32373faa5d16a
Autor:
Alexander R. Siebenhüner, Jean-Benoît Rossel, Philipp Schreiner, Matthias Butter, Thomas Greuter, Niklas Krupka, Sebastian B. U. Jordi, Luc Biedermann, Gerhard Rogler, Benjamin Misselwitz, Roland von Känel
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background and aims: Anxiety and depression are prevalent in patients with inflammatory bowel diseases (IBD), especially during IBD flares. IBD therapies can profoundly affect the mood of patients with IBD. We aimed to determine the long-term impact
Externí odkaz:
https://doaj.org/article/43745c5791f945d5ac13a25da3873fd3
Autor:
Tina Raselli, Tom Hearn, Annika Wyss, Kirstin Atrott, Alain Peter, Isabelle Frey-Wagner, Marianne R. Spalinger, Ewerton M. Maggio, Andreas W. Sailer, Johannes Schmitt, Philipp Schreiner, Anja Moncsek, Joachim Mertens, Michael Scharl, William J. Griffiths, Marco Bueter, Andreas Geier, Gerhard Rogler, Yuqin Wang, Benjamin Misselwitz
Publikováno v:
Journal of Lipid Research, Vol 60, Iss 7, Pp 1270-1283 (2019)
Nonalcoholic steatohepatitis (NASH), a primary cause of liver disease, leads to complications such as fibrosis, cirrhosis, and carcinoma, but the pathophysiology of NASH is incompletely understood. Epstein-Barr virus-induced G protein-coupled recepto
Externí odkaz:
https://doaj.org/article/71adacb59edc492490ef23699d5a4403